What's breaking now, across thousands of outlets.
(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity, two phase III trials showed. For the treatment...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
(MedPage Today) -- Musician and songwriter Billy Joel announced his first official show since his normal pressure hydrocephalus diagnosis.
While from a small study, the findings suggest PepGen’s therapy compares favorably to other RNA-based medicines in testing at Novartis and Dyne Therapeutics.
Cholera has killed more than 3,000 people worldwide since the start of the year, the World Health Organization said Tuesday, insisting its goal of cutting global cases by 90% by 2030 remained in…
(MedPage Today) -- Testosterone use among females has risen since 2016 and is frequently prescribed without a documented diagnosis of hypoactive sexual desire disorder, the sole evidence-based…
(MedPage Today) -- A single-use bioengineered liver paired with an extracorporeal blood circuit that replicates key functions of a human liver was shown to be safe among patients with syndromes of…
The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.
